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Abstract
 .The Shumiya cataract rat SCR is a hereditary cataract model in which lens opacity appears spontaneously in the nuclear
and perinuclear portions at 11–12 weeks of age. It was found that the proteolysis of some crystallins and cytoskeletal
proteins is significantly enhanced in cataractous SCR lenses. The calcium concentrations in cataractous lenses rise markedly
with age as compared with control lenses and the autolytic product of calpain is also detected in cataractous lenses. In order
to provide direct evidence for the involvement of calpain in the proteolytic modification of lens proteins, we developed
antibodies exclusively specific to the proteolytic products of some lens proteins produced by the action of calpain and
analyzed their degradation during cataractogenesis in SCR by Western blotting and immunohistochemical staining. The
results demonstrate that calpain participates in the proteolytic modification of lens proteins, at least a-crystallin A and B
.chain , bB1-crystallin, and a-fodrin. The proteolytic products formed by the action of calpain on these proteins are detected
in cataractous lenses of SCR as young as 8 weeks of age and accumulate with age. It was also found that bB1-crystallin,
originally a soluble protein, is converted to an insoluble form by limited calpain proteolysis. The chaperon-like activity of
a-crystallin from control lens is markedly reduced by calpain proteolysis in vitro, and a-crystallin in opaque lens that has
already undergone proteolysis by calpain shows significantly reduced chaperon-like activity. Immunohistochemical studies
reveal that the area where the calpain-mediated a-crystallin proteolysis is in progress coincides well with the area
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developing and destined to develop the opacification. These results strongly suggest that calpain may contribute to lens
opacification during cataract formation in SCR. q 1997 Elsevier Science B.V.
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1. Introduction
Calpain is an intracellular cysteine proteinase dis-
tributed in various tissues and cells. There are two
ubiquitous calpain isozymes, m- and m-calpains ac-
tive at mM and mM Ca2q concentrations, respec-
w xtively 1 . Both calpains are composed of a large
 .  .catalytic 80 kDa and a small regulatory 30 kDa
subunit and each subunit contains a calmodulin-like
domain at the C-terminus. Upon the binding of Ca2q
to the calmodulin-like domains, calpains become ac-
tive and begin to autolyze. In the case of m-calpain, it
is believed that the restricted autolysis in the large
subunit that accompanies the increase in calcium
w xsensitivity is itself the activation step 2–4 . On the
other hand, it has been reported that the large subunit
of mammalian m-calpain does not undergo autolysis
w xwithin the time span of substrate proteolysis 5 .
However, activated calpains degrade autolytically into
smaller fragments, even in the case of m-calpain,
when their substrate proteins are exhausted, and ulti-
mately lose proteolytic activity. Thus, the disappear-
ance of intact m-calpain and the appearance of its
fragments can be evidence of m-calpain activation.
Calpain is a major proteinase in lens and m-calpain is
w xthe predominant calpain species in rat lens 6 . Al-
though the exact physiological function of calpain is
not yet established, it has been suggested to play
important roles in cellular functions that occur in
w xresponse to mobilized calcium ions 7 . It seems
likely that the enzyme is involved not only in physio-
logical events but also in various pathological states,
w xincluding the development of cataracts 8 .
The proteolytic modification of lens proteins has
been observed in several experimental and hereditary
cataract models, such as cataracts induced by selenite
w x w x w x w x9 , sugar 10 , diamide 11 , hydrogen peroxide 12 ,
w x w xand U18666A 13 in rats and in Nakano 14 and
w xPhilly 15 hereditary cataractous mice. All these
cataract types show increased calcium concentrations
in the lens, and several findings suggest that the
activation of calpain contributes to the proteolysis of
lens proteins and cataract formation. However, no
direct evidence for the involvement of calpain in the
proteolytic modification of lens proteins has been
obtained, except in the case of b-crystallins. N-termi-
nal sequencing has revealed that the in vitro calpain
cleavage sites of b-crystallins match those found in
w xvivo in selenite-induced cataracts in rat 16 .
w xShumiya and Nagase 17 developed the Shumiya
 .cataract rat SCR , a new hereditary cataractous rat
strain, by cross-breeding a spontaneous hypertensive
rat and Zucker fatty rat. Lens opacity in SCR appears
spontaneously in the nuclear and perinuclear portions
w xat 11–12 weeks of age in 2r3 of animals 18 .
Raman optical dissection studies of the opaque lens
nucleus show a decreased content of lens protein
disulfide bonds and an increased content of sulfhydryl
groups. Oxidized glutathione concentrations are in-
creased and reduced glutathione levels are decreased
w x19 . On histopathological study, poorly differentiated
epithelial cells are seen at 2 weeks of age, and a
separated anterior suture and liquid accumulation in
the posterior subcapsular region are observed at 8
w xweeks 20 . However, the biochemical mechanism of
cataract formation in this model remains obscure, and
especially the proteolytic modification of lens pro-
teins has not yet been investigated. We, therefore,
examined the proteolytic modification of lens pro-
teins in SCR lenses. Our preliminary results showed
that the proteolysis of some lens proteins is signifi-
cantly enhanced in opaque SCR lenses. The protein
degradation patterns as well as the elevated calcium
concentrations in opaque lenses suggest the contribu-
tion of calpain to the proteolytic degradation of lens
proteins. Thus, to provide direct evidence for the
involvement of calpain in the proteolytic modifica-
tion of lens proteins during cataractogenesis in SCR,
we developed antibodies specific to the proteolytic
products of some lens proteins formed by calpain
action and analyzed their degradation during the pro-
cess of cataractogenesis in SCR by Western blotting
and immunohistochemical staining. The results show
that calpain participates in the proteolytic modifica-
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tion of lens proteins, at least a-crystallin A and B
.chain , bB1-crystallin, and a-fodrin, and that the
area in which calpain-mediated proteolysis is pro-
gressing coincides well with the areas of developing
and destined to develop opacification. The relation-
ship between the calpain-mediated proteolysis of lens
proteins and lens opacification is also discussed.
2. Materials and methods
2.1. Animals
SCR strain rats are maintained in this institute. The
rats examined were 8, 10, 12, and 14 weeks of age.
Lens opacity in SCR appears at 11–12 weeks of age
in exactly 2r3 of animals; the remainder have normal
clear lenses. In these experiments, therefore, the rats
 .were divided into two groups, i.e., control clear and
 .cataractous opaque . The judgment as to whether
individual rats would be opaque or clear was based
on observation with a slitlamp biomicroscope at 7
weeks of age. At this age, the lenses of all rats are
transparent by naked eye observation, but in lens
which will develop cataracts in the future, numerous
spoke-like radial stripes with a Y suture can be
observed by transillumination.
2.2. Reagents
m-Calpain was purified from bovine lung as previ-
w xously described 21 . Keyhole limpet hemocyanin
 .maleimide-activated was obtained from Boehringer
Mannheim. EDTA and diaminobenzidine were pur-
chased from Dojindo Laboratories. E-64c was a kind
gift from Taisho Pharmaceutical. PVDF membranes
were obtained from Bio-Rad. Peroxidase-conjugated
 .Xanti-mouse IgG Fab and anti-rabbit IgG were pur-
chased from Medical and Biological Labs and Seika-
 .gaku, respectively. Ampholine pH 3–10 was a
product of Pharmacia. FMP activated cellulofine was
purchased from Seikagaku. Other chemicals were
obtained from Nacalai Tesque and Wako.
2.3. Antibodies
A monoclonal antibody against the large subunit of
 .calpain 1D A was isolated as described before10 7
w x22 . Anti-a-fodrin and anti-vimentin monoclonal an-
tibodies were purchased from ICN Biochemicals and
Cymbus Bioscience, respectively. A polyclonal anti-
body specific to the calpain-generated 150 kDa frag-
 .ment of a-fodrin anti-a-fodrin fragment has been
w xdescribed previously 23 . Polyclonal antibodies
against the native forms and calpain-generated frag-
ments of crystallins were produced by immunizing
rabbits with synthetic peptide-carrier protein KLH,
.keyhole limpet hemocyanin conjugates. The calpain
cleavage sites in bB1-, a A-, and aB-crystallin have
w xbeen reported by David et al. 16 and Yoshida et al.
w x24 , respectively. Antibodies against the native forms
of bB1-, a A-, and aB-crystallins were produced
against synthetic peptides with the sequences MSQ-
 .VAKAAAT 1–10 of bB1; anti-bB1 crystallin , LP-
SNVDQSALSC 120–131 of a A; anti-a A crys-
. tallin , and MDIAIHHPWI 1–10 of aB; anti-aB
.crystallin , respectively. A cysteine residue was added
to the C-terminus of each peptide so that the hapten
could be conjugated to the carrier protein via a
sulfhydryl group, except for LPSNVDQSALSC. An-
tibodies against the calpain-generated fragments of
bB1-, a A-, and aB-crystallins were produced by the
 .peptide antigens TAPAPG anti-bB1 fragment ,
 . AIPVSR anti-a A fragment , and EKPAVT anti-aB
.fragment , respectively. These peptides were de-
 .signed to match the N-terminal for bB1-crystallin
 .or C-terminal for a A-crystallin and aB-crystallin
sequences of the proteolytic products produced by
calpain action. A cysteine residue was added to the
C- or N-terminus of each peptide. Rabbits were
immunized with the antigen–KLH conjugates 0.5–1
.mgrrabbit 5 times at intervals of 2–3 weeks, and
antisera were obtained 1–2 weeks after the final
booster shot. Affinity purification of polyclonal anti-
bodies was carried out using antigenic peptides im-
mobilized on FMP activated cellulofine.
2.4. Preparation of water-soluble and
water-insoluble lens proteins
Cataractous and control SCR rats were sacrificed
by an overdose of pentobarbital at 8, 10, 12, and 14
weeks of age, and the eyes were enucleated. Four to
six decapsulated lenses from each age group were
 .homogenized in 10 volumes vrw of 20 mM Tris–
 .HCl pH 7.5 containing 5 mM EDTA and 10 mM
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 .2-mercaptoethanol buffer A using a glass–glass
Dounce homogenizer. The homogenates were cen-
trifuged at 10000=g for 15 min at 48C and the
recovered supernatants were designated as the water-
 .soluble fraction WSF . The insoluble pellets were
washed three times with buffer A and the resulting
pellets were resuspended in buffer A to the original
volume of the whole homogenate and designated as
 .the water-insoluble fraction WIF .
2.5. Isolation of a-crystallin and bL-crystallin
fractions
The a-crystallin fraction was isolated from WSFs
of 12-week-old control and cataractous lenses by
FPLC on a Superdex 200 HR column 1=30 cm,
. Pharmacia . The bL-crystallin low molecular weight
.b-crystallins fraction was obtained from WSFs of
12-week-old control lenses by the same method.
2.6. Assay for chaperon-like acti˝ity
The chaperon-like activity was measured as the
ability to protect bL-crystallin against heat-induced
aggregation. Various amounts of a-crystallin prepara-
tion and 100 mg of bL-crystallin were mixed in a
cuvette and incubated at 568C in a Shimazu UV-160
spectrophotometer. All solutions were in 20 mM
 .imidazole pH 7.0 , 0.1 mM EGTA, 1 mM 2-mer-
captoethanol, and 80 mM NaCl in a total volume of
0.5 ml. Heat-induced aggregation was estimated as
the increase in the absorbance at 360 nm, which
reflects light scattering due to aggregation. Prior to
 y1.incubation with bL-crystallin 200 mg ml at 568C
for 10 min, a part of the a-crystallin preparation from
control lenses was incubated for 1 h at 308C with
purified bovine m-calpain in the presence or absence
of a calpain inhibitor, E-64c.
2.7. Two-dimensional gel electrophoresis
Two-dimensional gel electrophoresis of lens pro-
teins was performed according to the method of
w x  .O’Farrell 25 . Ampholine 3% vrv was used for pH
3–10. Isoelectric focusing was run in the first dimen-
sion and SDS–PAGE on 13.5% gels in the second
dimension. The proteins were visualized by staining
with Coomassie Brilliant Blue.
2.8. Western blot analysis
SDS–PAGE was carried out by the method of
w xLaemmli 26 in 13.5% polyacrylamide slab gels. The
proteins in the gels were transferred onto PVDF
membranes and the blotted proteins were incubated
with first antibodies followed by incubation with
peroxidase-conjugated anti-mouse IgG for calpain
. and native a-fodrin or anti-rabbit IgG for the cal-
pain-generated fragment of a-fodrin, and for native
.and calpain-generated fragments of crystallins as the
second antibody. The peroxidase stainings were de-
veloped with diaminobenzidine.
2.9. Immunohistochemistry
Eyes from cataractous and control SCR rats of
each age were fixed in methacarn solution
 .methanol–chloroform–glacial acetic acid, 6:3:1 for
20 h, embedded in paraffin wax, sectioned into 3 mm
thick slices with a microtome, deparaffinized with
xylene, and rehydrated. After rinsing in TBS 50 mM
.Tris–HClr150 mM NaCl, pH 7.6 , sections were
incubated for 30 min in 20% goat serum in TBS at
room temperature and then reacted with affinity puri-
 y1.fied first antibody 1 mg ml to native a-crystallins
or to the calpain-generated fragments of a-crystallins
in 10% goat serum in TBS at 48C overnight. After
washing with 0.05% Tween-20 in TBS, sections were
incubated with peroxidase-conjugated anti-rabbit IgG
for 1 h at room temperature. The sections were then
rinsed and immunoreactivity was visualized with
0.05% diaminobenzidine and 0.01% hydrogen perox-
 .ide in 50 mM Tris–HCl pH 7.6 . The stained sec-
tions were examined by light microscopy.
2.10. Calcium analysis
Lens dry weights were measured after heating at
1008C for 20 h. The lenses were then extracted with
0.2 ml concentrated HCl at room temperature
overnight and adjusted to 1.0 ml with NANO pure
water. The mixtures were centrifuged at 10000=g
for 10 min to remove insoluble material and the
calcium concentrations in the supernatant fractions
were measured by atomic absorption spectrophotome-
 .try on a Model Spectr AA-800 Varian .
( )M. Inomata et al.rBiochimica et Biophysica Acta 1362 1997 11–23 15
Fig. 1. Concentrations of total calcium in control and cataractous
 .opaque SCR lenses. Calcium concentration was determined by
atomic absorption spectrophotometry. Each point represents the
average of two lenses.
2.11. Protein determination
Protein concentrations were determined by BCA
 .assay Pierce using bovine serum albumin as the
standard.
3. Results and discussion
3.1. Acti˝ation of calpain in SCR lenses
Increased calcium concentrations in lenses have
been observed in several experimental and hereditary
rodent cataract models. Thus, we first analyzed
changes in calcium concentration during the process
 .of cataractogenesis in SCR lenses Fig. 1 . The con-
 .centration of total calcium in cataractous opaque
lenses was slightly elevated in rats as young as 8
weeks of age compared with control lenses, and rose
more markedly with age. At 14 weeks of age, the
calcium levels in the opaque lenses were about 6
times higher than in control lenses. Although we did
not examine free lens Ca2q concentrations separately,
it can be expected that they will also rise in propor-
tion to the increase in total calcium concentration, as
w xobserved in the case of selenite cataracts 27 . As
described in Section 1, activated calpain undergoes
autolytic degradation to smaller fragments when the
substrate proteins around it are exhausted. Therefore,
whether or not calpain is activated in tissues can be
evaluated by the detection of autolytic products. We
thus tried to detect autolytic calpain products in SCR
 .  .Fig. 2. Western blot analysis of calpain in control and cataractous opaque SCR lenses. The water-soluble fractions WSFs and
 .  .  .water-insoluble fractions WIFs prepared from control C and cataractous O SCR lenses were electrophoresed in 13.5% SDS–poly-
 .acrylamide gels and immunostained with a monoclonal antibody 1D A against the large subunit of calpain. The faint band indicated10 7
by the arrow is the autolytic degradation product of calpain. Rats were 8, 10, 12, and 14 weeks of age.
( )M. Inomata et al.rBiochimica et Biophysica Acta 1362 1997 11–2316
lenses by Western blot analysis. In the water-soluble
fraction from cataractous lenses, not only is the
amount of calpain 80 kDa subunit decreased with
age, but a new antibody-reactive band appears at
approximately 35 kDa as indicated by the arrow in
Fig. 2. The molecular weight of this new band is in
good agreement with the autolytic product of m-
w xcalpain 28 . It should be noted that the autolytic
product was detected in cataractous lenses of rats as
young as 8 weeks of age. However, no dramatic
 .changes in the autolytic product 35 kDa of catarac-
tous lenses, such as accumulation with age, were
observed. The 35 kDa calpain fragment may exist
only transiently, be further degraded into smaller
fragments, and not accumulate quantitatively. The
changes in the calcium concentration and molecular
weight of calpain indicate that calpain is activated
during the process of cataractogenesis in SCR.
3.2. Proteolysis of lens proteins
Fig. 3 shows the electrophoresis patterns of the
water-soluble and water-insoluble proteins from 14-
week-old control and opaque lenses. In the water-
soluble fraction from opaque lenses, the intensities of
the 32, 24.5, 23.5, and 22 kDa lens crystallin bands
are significantly lower than in control lenses, and
new polypeptide bands at 26, 21.5, and 20.5 kDa are
seen to accumulate. In the case of the water-insoluble
proteins from opaque lenses, decreases in the 230,
88, and 57 kDa bands are observed. Western blot
analysis confirmed that the 230 and 57 kDa poly-
peptides are fodrin and vimentin, respectively data
.not shown . These results suggest that the proteolysis
of several proteins is enhanced in cataractous SCR
lens. We then compared the water-soluble proteins
from opaque lens and calpain-treated water-soluble
proteins from control lens by two-dimensional elec-
trophoresis in order to determine whether calpain is
involved in the proteolytic modification of lens pro-
 .teins in opaque SCR lens Fig. 4 . The electrophore-
sis pattern of the water-soluble proteins from opaque
 . lens shows decreases in bB1- spot a8 , bA3- spot
.  .a7 , and g-crystallins spot a1 and increases in
 .smaller peptides around a A-crystallin spot a10 as
compared with control lens. Similar changes can be
induced by incubating the water-soluble proteins from
control lens with calpain, except for the decrease in
Fig. 3. Electrophoresis of water-soluble and water-insoluble pro-
 .teins from control and cataractous opaque SCR lenses. WSFs
and WIFs prepared from 14-week-old control and cataractous
 .opaque SCR lenses were electrophoresed in 13.5% SDS–poly-
 .acrylamide gels and stained with Coomassie Brilliant Blue. A
 .  . WSFs and WIFs from control C and opaque O lenses equal
.volumes; 63, 31, 44, and 55 mg protein from left to right were
 .electrophoresed. B Samples containing one-fifth the amount of
protein as in panel A were electrophoresed to obtain good
resolution in the area of the crystallins.
g-crystallins. The changes are blocked by the omis-
sion of calcium ions or the addition of calpain in-
 .hibitors such as E-64c or leupeptin data not shown .
These results strongly suggest that calpain is involved
in the proteolytic modification of some lens crys-
tallins during cataractogenesis in SCR. As in opaque
lens, the amount of g-crystallins does not decrease
with calpain treatment. It has been suggested that the
reduction of g-crystallins in cataractous rodent lens is
entirely due to leakage from the lens into the aqueous
w xand vitreous humors 29 .
3.3. Production of antibodies exclusi˝ely specific to
the calpain-generated fragments of lens proteins
In order to demonstrate more directly the involve-
ment of calpain in the proteolysis of lens proteins, we
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 .Fig. 4. Two-dimensional electrophoresis of water-soluble proteins from control and cataractous opaque SCR lenses. Two-dimensional
electrophoresis was performed using pH 3–10 ampholine and 13.5% SDS–polyacrylamide gels. Left panel, water-soluble proteins 50
.  .mg from 14-week-old control lens. Middle panel, water-soluble proteins 50 mg from 14-week-old control lens after incubation with
 .  .purified m-calpain. Right panel, water-soluble proteins 50 mg from 14-week-old cataractous opaque lens. Polypeptides are numbered
 .  .  .  .  .  .  .from left to right and tentatively identified as 1 g-crystallins, 2 bB3-, 3 aB-, 4 unknown, 5 bB2-, 6 a A - qbA1-, 7 , bA3-,ins
 .  .  .8 bB1-, 9 bA4-, and 10 a A-crystallins, based on comparison with the reported two-dimensional electrophoresis pattern of rat
w xcrystallins 31 .
developed antibodies exclusively specific to the cal-
pain-generated fragments of some lens proteins. These
antibodies were developed using synthetic peptides
by a method similar to that used to produce antisera
to the 150 kDa fragment of a-fodrin proteolyzed by
w xcalpain 23 . As shown in Fig. 5, the antigen peptides
Fig. 5. Design of synthetic peptides for the production of antibodies specific to the calpain-generated fragments of crystallins. Antigen
 .  .  .peptides 6-mer were designed to match the newly-generated N- for bB1-crystallin or C-terminal for a A-, and aB-crystallins
 .sequences of the proteolytic products of crystallins formed by calpain action. A cysteine residue was added to the C- for bB1-crystallin
 .or N-terminus for a A-, and aB-crystallins of each peptide so that the hapten could be conjugated to the carrier protein via its sulfhydryl
group. Antibodies against the native forms of these crystallins were produced against synthetic peptides corresponding to the underlined
amino acid sequences. A cysteine residue was also added to the C-terminus of each peptide except for a A-crystallin. For details, see
Section 2.
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were designed to match the newly generated N- or
C-terminal sequences of the proteolytic products of
crystallins formed by calpain action. Antibodies
against the native forms of crystallins were produced
using synthetic peptides with the underlined se-
quences. To evaluate antibody specificity, the water-
soluble fraction from 14-week-old control lenses was
treated with purified m-calpain and the products were
 .analyzed by Western blotting Fig. 6 . All of the
antibodies against fragments of crystallins recognized
only one fragment of a A-, aB-, or bB1-crystallins
generated by calpain action and did not react with
their respective intact forms. The generation of anti-
body-reactive fragments is blocked by E-64c, a cal-
pain inhibitor. Furthermore, we checked whether these
antibodies are reactive with the degradation products
of crystallins produced by trypsin or a-chymotrypsin.
None of the antibodies, except the anti-aB fragment
antibody, react with any of these degradation prod-
 .ucts data not shown . From these results, we con-
clude that at least the anti-a A fragment and anti-bB1
fragment antibodies are specific for calpain-catalyzed
degradation products, recognizing the newly gener-
ated C- and N-terminal portion, respectively. On the
other hand, the anti-aB fragment antibody recognizes
the degradation product formed by a-chymotrypsin.
This indicates that the cleavage site of a-chymotryp-
sin in aB-crystallin is identical to that of calpain.
However, the degradation of aB-crystallin by a-
chymotrypsin in vitro rapidly proceeds further to
 .produce smaller fragments data not shown . In con-
trast, the anti-aB fragment antibody-reactive frag-
 .ment produced by calpain in vitro Fig. 6B and that
 .generated in cataractous SCR lens in vivo Fig. 8 are
very stable. Therefore, it seems likely that the frag-
ment generated in cataractous lenses that reacts with
the anti-aB fragment antibody is also produced by
calpain but not by a-chymotrypsin or any a-
chymotrypsin-like proteinase.
3.4. Proteolytic modification of lens proteins by cal-
pain during cataractogenesis in SCR
Proteolytic modification of lens proteins during
cataractogenesis in SCR was analyzed by Western
blotting using antibodies against calpain-generated
 .fragments of a-crystallin A and B chain and bB1-
Fig. 6. Characterization of antibodies specific to the calpain-gen-
erated fragments of crystallins. The water-soluble proteins from
14-week-old control lenses were subjected to proteolysis by
purified m-calpain for different lengths of time in the presence or
absence of E-64c, a calpain inhibitor, and the degradation prod-
 .ucts were analyzed by Western blotting. A immunostained with
 .anti-a A crystallin antibody or anti-a A fragment antibody. B
immunostained with anti-aB crystallin antibody or anti-aB frag-
 .ment antibody. C immunostained with anti-bB1 crystallin anti-
body or anti-bB1 fragment antibody.
crystallin. As shown in Figs. 7–9, these antibody-re-
active fragments are detected predominantly in
cataractous lenses. We also confirmed the presence of
the calpain-generated 150 kDa fragment of a-fodrin
in cataractous lenses using anti-a-fodrin fragment
 .antibody data not shown . Despite considerable evi-
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 .Fig. 7. Western blot analysis of the calpain-generated fragment of a A-crystallin in control and cataractous opaque SCR lenses. WSFs
 .  .  .and WIFs prepared from control C and cataractous O lenses equal in volume were electrophoresed in 13.5% SDS–polyacrylamide
 .  .gels and immunostained with the anti-a A crystallin antibody upper panel or anti-a A fragment antibody lower panel . The rats were 8,
10, 12, and 14 weeks of age.
dence that calpain activation is associated with the
proteolytic modification of these lens proteins in
various cataracts, the correlation has not yet been
w xproved definitely 9–14,30 . However, the following
evidence indicates that the generation of antibody-re-
active fragments is caused by calpain action: The
 .Fig. 8. Western blot analysis of the calpain-generated fragment of aB-crystallin in control and cataractous opaque SCR lenses. WSFs
 .  .  .and WIFs prepared from control C and cataractous O lenses equal in volume were electrophoresed in 13.5% SDS–polyacrylamide
 .  .gels and immunostained with the anti-aB crystallin antibody upper panel or anti-aB fragment antibody lower panel . The rats were 8,
10, 12, and 14 weeks of age.
( )M. Inomata et al.rBiochimica et Biophysica Acta 1362 1997 11–2320
antibody specificity, the coincidence of the increasing
 .lens calcium concentration Fig. 1 , the autolytic
 .tendency of calpain Fig. 2 , and the behavior of lens
 .protein degradation products Figs. 7–9 . Based on
these findings, it can be concluded that calpain partic-
ipates in the proteolytic modification of lens proteins,
 .at least a-crystallin A and B chain , bB1-crystallin,
and a-fodrin in SCR lens. As far as we know, this is
the first report that the proteolytic modification of
 .a-crystallin A and B chain and a-fodrin in lens is
in fact catalyzed by calpain. These results also show
that the calpain-mediated proteolysis of these proteins
occurs as early as 8 weeks and that proteolytic frag-
ments accumulate in cataractous lenses with age. We
further noticed an interesting phenomenon that seems
closely related to lens opacification, namely, that the
calpain-generated fragment of bB1-crystallin exists
predominantly in the water-insoluble fraction, al-
though the intact form is originally in the soluble
 .fraction Fig. 9 . This clearly demonstrates that
bB1-crystallin is converted from a soluble to an
insoluble form by calpain proteolysis. Concerning
this point, our conclusion is consistent with that of
w xDavid and coworkers 16,31 , although the experi-
mental approaches and types of cataract are not iden-
tical. In addition, an accumulation of the calpain-gen-
erated fragment of bB1-crystallin was observed in
control as well as in cataractous lenses, also in agree-
w xment with the results of David et al. 32 .
3.5. Chaperon-like acti˝ity of a-crystallin from SCR
lens
It is well-known that a-crystallins have a chap-
eron-like activity that suppresses the heat-induced
w xaggregation of other proteins 33 . This chaperon-like
activity decreases in aged lens and a-crystallins un-
dergo cleavage at their C-termini during lens aging
w x w x34,35 Moreover, Kelley et al. 36 reported that the
chaperon-like activity of a-crystallin is reduced by
m-calpain action in vitro and in selenite-induced
cataracts. As described above, we confirmed that
a A- and aB-crystallins are modified proteolytically
at their C-termini by calpain and that the proteolytic
products accumulate in lens during cataractogenesis
in SCR. Therefore, we also examined the effect of
calpain on the chaperon-like activity of a-crystallin
in vitro and in SCR. As shown in Fig. 10, the
incubation of partially purified a-crystallin from con-
trol lens with calpain results in a marked reduction in
chaperon-like activity, while a-crystallin from opaque
lens, which has suffered proteolysis by calpain, also
shows a moderately reduced chaperon-like activity.
 .Fig. 9. Western blot analysis of the calpain-generated fragment of bB1-crystallin in control and cataractous opaque SCR lenses. WSFs
 .  .  .and WIFs prepared from control C and cataractous O lenses equal in volume were electrophoresed in 13.5% SDS–polyacrylamide
 .  .gels and immunostained with the anti-bB1 crystallin antibody upper panel or anti-bB1 fragment antibody lower panel . The rats were
8, 10, 12, and 14 weeks of age.
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Fig. 10. Effect of calpain-dependent proteolysis on the chaperon-
like activity of a-crystallin. Chaperon-like activity was measured
as the ability to protect bL-crystallin against heat-induced aggre-
gation. Various amounts of a-crystallin preparation and bL-
 y1.crystallin 200 mg ml were mixed in a cuvette and incubated
at 568C for 10 min in the sample chamber of a spectrophotom-
eter. Heat-induced aggregation was estimated from the increase
in the absorbance at 360 nm, which reflects light scattering due to
aggregation. The mean variation for duplicate determinations for
 .  .each point was "3%. ‘ , a-crystallin from control lenses; v ,
 .control lens a-crystallin pre-treated with purified m-calpain; ’ ,
control lens a-crystallin pre-treated with m-calpain in the pres-
 .ence of the inhibitor, E-64c; B a-crystallin from cataractous
 .opaque lenses. For details, see Section 2.
3.6. Immunohistochemical localization of the
calpain-mediated proteolysis of a-crystallin in SCR
lens
The above results clearly demonstrate that calpain
participates in the proteolytic modification of several
proteins in cataractous SCR lenses. However, a de-
tailed mechanism that links calpain-mediated proteol-
ysis and lens opacification has not yet been eluci-
dated. Therefore, we carried out immunohistochemi-
cal tests on SCR lenses during cataractogenesis to
determine whether the area where the calpain-media-
ted proteolytic products appear coincides spatially
with the area in which opacity has developed morbid
.area . Fig. 11 demonstrates the occurrence of a cal-
pain-generated fragment of aB-crystallin in catarac-
tous SCR lenses. In control lens of any age, very
little anti-aB fragment antibody staining is observed
 .upper panel in B , consistent with the results of
Western blotting shown in Fig. 8. This indicates that
aB-crystallin basically exists in an intact form under
physiological conditions. In clear contrast, immuno-
reactivity corresponding to the aB-crystallin frag-
ment is quite evident in the perinuclear region of
cataractous lens as young as 8 weeks of age lower
.panel in B . This immunoreactivity increases
markedly with age and ultimately spreads to the
entire nuclear region of lenses that showed little
immunoreactivity at 10 weeks or less. However, very
little immunoreactivity is observed in the cortical
region where opacity has not developed. Almost the
same results were obtained in an immunohistochemi-
cal study using the anti-a A fragment antibody except
that immunoreactive staining was seen to extend
 .slightly into the cortical region data not shown . No
immunoreactive staining was observed with preim-
mune rabbit IgG or anti-a A- and -aB fragment
antibodies adsorbed to individual antigenic peptides
 .data not shown . It is difficult to determine whether
calpain-mediated a-crystallin proteolysis precedes the
onset of the earliest stages of opacification, since
there is no way to judge whether the lenses of
individual rats would be opaque or normal clear
before 7 weeks of age. However, the above results
clearly show that at least the area in which calpain-
mediated a-crystallin proteolysis occurs coincides
with the area of developing and destined to develop
opacification, namely the perinuclear and nuclear re-
gions. To our knowledge, this is the first report of the
spatial localization of calpain-mediated proteolytic
products, demonstrating the loci of calpain activation,
in cataractous lens.
Neither a A- nor aB-crystallin is converted from
the soluble to insoluble form by calpain proteolysis in
the lens during cataractogenesis, unlike bB1-crystal-
 .lin Figs. 7–9 . As shown in Fig. 10, however,
limited proteolysis of a-crystallin by calpain results
in a loss of chaperon-like activity. In the present
study, the chaperon-like activity of a-crystallin was
evaluated only in terms of its ability to protect bL-
crystallin against heat-induced aggregation, but it is
conceivable that a reduction in a-crystallin function
promotes the denaturation and aggregation of other
lens proteins that have been implicated in lens opaci-
fication. There are some reports that native a-crystal-
lin associates with lens fiber cell membranes and the
cytoskeleton, notably the intermediate filaments
w x37,38 , and that the chaperon-like activity of a-
crystallin is involved in intermediate filament assem-
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Fig. 11. Immunohistochemical localization of calpain-mediated proteolysis of aB-crystallin in SCR lenses during cataractogenesis.
 .Sections prepared from control and cataractous SCR eyes of various ages were immunostained with anti-aB crystallin antibody A or
 .anti-aB fragment antibody B . For details, see Section 2. In both A and B, the upper panels show lenses from control SCR and the lower
panels show lenses from cataractous SCR. The rats were 8, 10, 12, and 14 weeks of age. Magnification, =5.
w xbly 39 . Therefore, it is conceivable that the chap-
eron-like activity of a-crystallin also plays an impor-
tant role in the maturation of fiber cells and the
maintenance of cell shape.
As stated above, our findings suggest that calpain
may contribute to lens opacification during cataract
formation in SCR. On the basis of the existing data,
we believe that capain-mediated proteolysis con-
tributes to the development of lens opacification
 .through direct as in the case of bB1-crystallin
 .andror indirect effects as in the case of a-crystallin
leading to the formation of insoluble lens proteins.
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Calpain-mediated proteolysis occurs predominantly
in the central area of the lens, i.e., in the perinuclear
and nuclear regions as shown in Fig. 11. This obser-
vation suggests that Ca2q concentrations in the cen-
tral area are greater than physiological levels. If so, a
new question must be asked. What is the mechanism
by which the Ca2q concentration rises only in the
central area without adversely affecting the epithelial
and cortical regions? At present, we have no good
answer for this question. The elucidation of the above
mechanism, however, may provide an important clue
about the formation of nuclear cataracts. This will be
the subject of future studies.
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